Moderna: Vaccine Produced Strong Immune Results In Kids

The trial has not been peer-reviewed or published yet, but the company is planning on submitting these results to the FDA.

Moderna says its vaccine seems to be working in younger kids.

The pharmaceutical company says its trial results show smaller doses generated a strong immune response in children between the ages of six and 11.

Moderna says antibody response kicked in one month after the second dose.